The Whitecoated Worker in the High Performance Company

The environment within which the pharmaceutical industry is operating is dynamic and highly competitive. Government cost- cutting in healthcare, the rise of generic drugs, increasing R&D costs and depreciating patent lives are having important effects upon the sector (Sharp 1991). Recent years h...

Full description

Saved in:
Bibliographic Details
Published inManagement research news Vol. 19; no. 4/5; pp. 25 - 27
Main Author Randle, Keith
Format Journal Article
LanguageEnglish
Published Patrington MCB UP Ltd 01.04.1996
Emerald Group Publishing Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The environment within which the pharmaceutical industry is operating is dynamic and highly competitive. Government cost- cutting in healthcare, the rise of generic drugs, increasing R&D costs and depreciating patent lives are having important effects upon the sector (Sharp 1991). Recent years have witnessed a wave of takeover, merger and restructuring. The need to discover, develop and market drugs rapidly is greater than ever before. Consequently, high performance is seen as vital both by analysts of the sector and by managers in the company which forms the subject of this paper. This is not unproblematic in a research- based industry, there may be conflicts between short-term and long-term objectives and there is no simple relationship between individual high performance and high performance as an organisation.
Bibliography:filenameID:0210190408
href:eb028452.pdf
original-pdf:0210190408.pdf
istex:07512E6E46EDA9D955F53C80EFA243643AFD3B9B
ark:/67375/4W2-L0FQW033-4
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0140-9174
2040-8269
1758-6135
2040-8277
DOI:10.1108/eb028452